chevron_leftBack
As of 17 June 2026, Atlantic International Corp. has a market cap of $41.71M USD, ranking #31903 globally and #4577 in the United States.
It ranks #2886 in the Healthcare sector, and #1001 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$41.71MUSD
Enterprise Value
$255.83MUSD
Revenue (TTM)
$435.88MUSD
EBITDA (TTM)
-$45.3MUSD
Net Income (TTM)
-$59.43MUSD
EBITDA Margin
-10%
Profit Margin
-14%
PS Ratio
0.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jeffrey Jagid
open_in_new
Employees
300
Founded
2014
IPO
27 Aug 2021
Website
atlantic-international.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -15% | -12% | -45% | -49% | -35% | -50% |
News
Loading...
ATLN Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ATLN
Atlantic International Corp
ISIN: US0485921094
Shares Out.:
Shares Outstanding:
79.358M1
Shares Float:
25.394M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
1.76 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Atlantic International Corp.
Atlantic International Corp. operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, staffing, light industrial, and medical fields. It also provides productivity consulting and workforce management solutions. The company was founded in 2018 and is based in Englewood Cliffs, New Jersey.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
1M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
865K%
|
97.4
|
|
NYSE: MRK
|
$274.03B
657K%
|
15.1
|
|
NYSE: PFE
|
$149.38B
358K%
|
19.5
|
|
NYSE: BMY
|
$117.58B
282K%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$322.73B
774K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
693K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
661K%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$182.39B
437K%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$110.46B
265K%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$108.64B
260K%
80.96B GBP
|
14.6
|
chevron_leftBack